Abingdon Health Plc (LON:ABDX – Get Free Report)’s stock price traded up 0.8% during trading on Thursday. The company traded as high as GBX 11 and last traded at GBX 10.84. 109,810 shares changed hands during trading, a decline of 53% from the average daily volume of 235,236 shares. The stock had previously closed at GBX 10.75.
Abingdon Health Stock Up 0.7%
The company has a current ratio of 1.91, a quick ratio of 1.96 and a debt-to-equity ratio of 15.05. The firm’s 50 day simple moving average is GBX 10.75 and its two-hundred day simple moving average is GBX 10.46. The firm has a market cap of £27.35 million, a price-to-earnings ratio of -13.36 and a beta of 0.13.
Abingdon Health Company Profile
Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval. The Company also markets its own range of self-tests under the Abingdon Simply Test brand (www.abingdonsimplytest.com) and has developed and marketed its own labelled tests.
Recommended Stories
- Five stocks we like better than Abingdon Health
- Schneider Just Paid Up for PTC—Is the SaaSpocalypse Overdone?
- Delta Air Lines Faces a Fuel Crisis—But There’s a Silver Lining
- Is Synopsys Back from the Dead? EDA Leader Inks Deals With Amazon and OpenAI
- MarketBeat Week in Review – 10/05 – 10/09
Receive News & Ratings for Abingdon Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abingdon Health and related companies with MarketBeat.com's FREE daily email newsletter.
